Group 1 - The company, BenQ Hospital, plans to globally offer 67 million shares, with 6.7 million shares available in Hong Kong and 60.3 million shares for international sale [1] - The subscription period is set from December 12 to December 17, with a maximum offer price of HKD 11.68 per share and an entry fee of approximately HKD 5,898.90 for a trading unit of 500 shares [1] - The total expected fundraising amount is HKD 704 million, with a net amount of HKD 626 million, which will be used for hospital expansion and upgrades, potential investments and acquisitions, smart hospital upgrades, and general working capital [1] Group 2 - The company has introduced cornerstone investors including He Rong Technology Co., Ltd., He Fu (China) Medical Technology Co., Ltd., and Suzhou Zhanxing Investment Fund Partnership [1] - BenQ Hospital is expected to be listed on the main board by December 22, 2025, with China International Capital Corporation Hong Kong Securities Limited and Citigroup Global Markets Asia Limited acting as joint sponsors [1] - The company draws on advanced hospital management experience from Taiwan and operates as a private for-profit general hospital group in mainland China [1] Group 3 - For the fiscal years 2023, 2024, and the first half of 2025 ending June 30, the company's net profits are projected to be CNY 167 million, CNY 109 million, and CNY 48.704 million, reflecting year-on-year changes of 86.99%, -34.95%, and -23.18% respectively [2]
明基医院 12月12日—12月17日招股